Laurence W. Lytton - Significant Ownership

Signature - Title
/s/ Laurence W. Lytton - Reporting Person
Location
NY, NY
Summary
This page shows a list of all the recent SCHEDULE 13D/G filings made by Laurence W. Lytton.

Significant Ownership of Laurence W. Lytton

Sym Company Class Ownership Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
LIQT LIQTECH INTERNATIONAL INC Common Stock 9.99% $2.78M 1.06M Lytton-Kambara Foundation Sep 30, 2025
AYTU AYTU BIOPHARMA, INC Common Stock 9.99% $1.86M $992K 1.09M +114% LYTTON LAURENCE W Sep 30, 2025
GUER GUERRILLA RF, INC. Common Stock 9.99% $1.14M 1.09M Lytton, Laurence W. Mar 28, 2024
APRE Aprea Therapeutics, Inc. Common Stock 9.9% $914K 682K LYTTON LAURENCE W Nov 13, 2025
CLRB Cellectar Biosciences, Inc. Common Stock 8.8% $1.07M 3.96M LYTTON LAURENCE W Dec 31, 2024
TLPH TALPHERA, INC. Common Stock 8% $1.89M 3.64M LYTTON LAURENCE W Sep 10, 2025
SONM SONIM TECHNOLOGIES INC Common Stock 7.8% $52K -$590K 79.9K -91.9% LYTTON LAURENCE W Sep 30, 2025
TELA TELA Bio, Inc. Common Stock 7.2% $4.27M -$833K 2.87M -16.3% Lytton, Laurence W. Sep 30, 2025
XTNT Xtant Medical Holdings, Inc. Common Stock 6.8% $4.45M 9.46M Laurence W. Lytton Apr 15, 2025
MDXH MDxHealth SA Ordinary Shares 6.4% $14.7M -$3.66M 3.16M -19.9% LYTTON LAURENCE W Sep 30, 2025
CREX CREATIVE REALITIES, INC. Common Stock 5.1% $1.22M $213K 534K +21.1% LYTTON LAURENCE W Oct 28, 2025
DUOT DUOS TECHNOLOGIES GROUP, INC. Common Stock 4.99% $2.41M 427K LYTTON LAURENCE W Jan 31, 2024
SMTK SmartKem, Inc. Common Stock 4.9% $646K -$321K 223K -33.2% Lytton, Laurence W. Mar 31, 2025
ELVA Electrovaya Inc. Common Shares 4.7% $11.5M -$3.29M 1.9M -22.3% Lytton, Laurence W. Jun 30, 2025
EVOK Evoke Pharma Inc Common Stock, par value $0.0001 3.9% $138K 61.3K Lytton, Laurence W. Mar 31, 2025
BFRI Biofrontera Inc. Common Stock, par value $0.001 3.5% $245K 307K LYTTON LAURENCE W Mar 31, 2025
NMTC NEUROONE MEDICAL TECHNOLOGIES Corp Common Stock, par value $0.001 2.6% $609K 1.3M LYTTON LAURENCE W Mar 31, 2025
CLRB Cellectar Biosciences, Inc. Common Stock 1.6% $248K 51.4K LYTTON LAURENCE W Jun 30, 2025
EMKR EMCORE CORP Common Stock 1.4% $395K 127K LYTTON LAURENCE W Dec 31, 2024
XGN EXAGEN INC. Common Stock, par value $0.001 per share 1% $2.14M 217K LYTTON LAURENCE W Jun 30, 2025
SCPH scPharmaceuticals Inc. Common Stock 0% $0 0 LYTTON LAURENCE W Sep 30, 2025

Schedules 13D/G Reported by Laurence W. Lytton:

Sym Target Class Ownership Change Current Shares Change Value Reporting name Form Report Period Date Filed
* An asterisk sign (*) next to the price indicates that the price is likely invalid.